385 related articles for article (PubMed ID: 18461629)
1. Efficient neutralizing activity of cocktailed recombinant human antibodies against hepatitis A virus infection in vitro and in vivo.
Cao J; Meng S; Li C; Ji Y; Meng Q; Zhang Q; Liu F; Li J; Bi S; Li D; Liang M
J Med Virol; 2008 Jul; 80(7):1171-80. PubMed ID: 18461629
[TBL] [Abstract][Full Text] [Related]
2. [Baculovirus expression of two human recombinant neutralizing IgG monoclonal antibodies to hepatitis A virus].
Cao JY; Liang MF; Meng QL; Wang XF; Xu YG; Guo KQ; Zhan MY; Bi SL; Li DX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):20-3. PubMed ID: 15340519
[TBL] [Abstract][Full Text] [Related]
3. Neutralizing human monoclonal antibodies to hepatitis A virus recovered by phage display.
Kim SJ; Jang MH; Stapleton JT; Yoon SO; Kim KS; Jeon ES; Hong HJ
Virology; 2004 Jan; 318(2):598-607. PubMed ID: 14972527
[TBL] [Abstract][Full Text] [Related]
4. Human Fab antibodies derived from phage display library neutralize hepatitis A virus in vitro.
Cao J; Liang M; Guo K
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):313-6. PubMed ID: 11471014
[TBL] [Abstract][Full Text] [Related]
5. Characterization of anti-idiotypic antibodies mimicking antibody- and receptor-binding sites on hepatitis A virus.
Kiyohara T; Totsuka A; Yoneyama T; Ishii K; Ito T; Wakita T
Arch Virol; 2009; 154(8):1263-9. PubMed ID: 19578927
[TBL] [Abstract][Full Text] [Related]
6. Four chimpanzee monoclonal antibodies isolated by phage display neutralize hepatitis a virus.
Schofield DJ; Satterfield W; Emerson SU; Purcell RH
Virology; 2002 Jan; 292(1):127-36. PubMed ID: 11878915
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of recombinant human anti-HAV monoclonal antibody.
Wei JS; Tao R; Sun WW; Jia Q; Li C; Liang MF
Sheng Wu Gong Cheng Xue Bao; 2004 Mar; 20(2):257-61. PubMed ID: 15969118
[TBL] [Abstract][Full Text] [Related]
8. [Immunogenicity of experimentally combined hepatitis A and hepatitis E vaccine at different dosage ratio].
Dong C; Dai X; Meng JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):130-3. PubMed ID: 17286906
[TBL] [Abstract][Full Text] [Related]
9. Identification of hepatitis A virus mimotopes by phage display, antigenicity and immunogenicity.
Larralde OG; Martinez R; Camacho F; Amin N; Aguilar A; Talavera A; Stott DI; Perez EM
J Virol Methods; 2007 Mar; 140(1-2):49-58. PubMed ID: 17129616
[TBL] [Abstract][Full Text] [Related]
10. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
[TBL] [Abstract][Full Text] [Related]
11. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India?
Anand AC; Nagpal AK; Seth AK; Dhot PS
J Assoc Physicians India; 2004 Oct; 52():785-7. PubMed ID: 15909855
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic relevance of immunoglobulin G avidity for hepatitis A virus.
Roque-Afonso AM; Grangeot-Keros L; Roquebert B; Desbois D; Poveda JD; Mackiewicz V; Dussaix E
J Clin Microbiol; 2004 Nov; 42(11):5121-4. PubMed ID: 15528704
[TBL] [Abstract][Full Text] [Related]
13. The first experimental study on a candidate combined vaccine against hepatitis A and hepatitis E.
Dong C; Dai X; Meng JH
Vaccine; 2007 Feb; 25(9):1662-8. PubMed ID: 17156900
[TBL] [Abstract][Full Text] [Related]
14. Epitope-based recombinant diagnostic antigen to distinguish natural infection from vaccination with hepatitis A virus vaccines.
Su Q; Guo M; Jia Z; Qiu F; Lu X; Gao Y; Meng Q; Tian R; Bi S; Yi Y
J Virol Methods; 2016 Jul; 233():41-5. PubMed ID: 26994964
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis A virus antibodies in immunoglobulin preparations.
Farcet MR; Planitzer CB; Stein O; Modrof J; Kreil TR
J Allergy Clin Immunol; 2010 Jan; 125(1):198-202. PubMed ID: 19962745
[TBL] [Abstract][Full Text] [Related]
17. Experimental hepatitis A virus (HAV) infection in Callithrix jacchus: early detection of HAV antigen and viral fate.
Pinto MA; Marchevsky RS; Baptista ML; de Lima MA; Pelajo-Machado M; Vitral CL; Kubelka CF; Pissurno JW; Franca MS; Schatzmayr HG; Gaspar AM
Exp Toxicol Pathol; 2002 Feb; 53(6):413-20. PubMed ID: 11930901
[TBL] [Abstract][Full Text] [Related]
18. [Studies on vaccination schedule of inactivated hepatitis A vaccine].
Hu Y; Tan S; Jin W
Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):618-20. PubMed ID: 11798830
[TBL] [Abstract][Full Text] [Related]
19. Rapid detection of anti-hepatitis A virus neutralizing antibodies in a microplate enzyme immunoassay.
Azizi A; Sirskyj D; Weltzin R; Anderson DE; Diaz-Mitoma F
J Med Microbiol; 2009 Nov; 58(Pt 11):1433-1436. PubMed ID: 19608692
[TBL] [Abstract][Full Text] [Related]
20. Applied biotechnology for production of immunoglobulin Y specific to hepatitis A virus.
de Paula VS; da Silva Ados S; de Vasconcelos GA; Iff ET; Silva ME; Kappel LA; Cruz PB; Pinto MA
J Virol Methods; 2011 Jan; 171(1):102-6. PubMed ID: 20971134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
